One Capital Management LLC Sells 456 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

One Capital Management LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 30.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,062 shares of the medical equipment provider’s stock after selling 456 shares during the quarter. One Capital Management LLC’s holdings in Intuitive Surgical were worth $554,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ISRG. Massachusetts Financial Services Co. MA purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $558,807,000. Proficio Capital Partners LLC raised its holdings in Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after buying an additional 948,902 shares during the period. FMR LLC raised its holdings in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the period. Raymond James Financial Inc. purchased a new stake in Intuitive Surgical during the 4th quarter valued at $313,769,000. Finally, Wilmington Savings Fund Society FSB raised its holdings in Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $518.26 on Friday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock’s 50-day moving average is $571.36 and its 200 day moving average is $531.20. The company has a market cap of $184.59 billion, a P/E ratio of 80.85, a PEG ratio of 5.85 and a beta of 1.43.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now directly owns 473 shares in the company, valued at approximately $271,397.94. The trade was a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,579 shares of company stock valued at $7,756,844 over the last quarter. 0.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Jefferies Financial Group increased their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Barclays increased their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Citigroup increased their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Finally, Truist Financial increased their price target on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.